Published in J Immunol on January 15, 2007
Current challenges in the development of vaccines for pneumonic plague. Expert Rev Vaccines (2008) 1.71
Immune defense against pneumonic plague. Immunol Rev (2008) 1.44
Braun lipoprotein (Lpp) contributes to virulence of yersiniae: potential role of Lpp in inducing bubonic and pneumonic plague. Infect Immun (2008) 1.24
Analysis of type II secretion of recombinant pneumococcal PspA and PspC in a Salmonella enterica serovar Typhimurium vaccine with regulated delayed antigen synthesis. Infect Immun (2008) 1.23
Salmonella enterica serovar Typhi live vector vaccines finally come of age. Immunol Cell Biol (2009) 1.21
Effective plague vaccination via oral delivery of plant cells expressing F1-V antigens in chloroplasts. Infect Immun (2008) 1.18
Oral live vaccine strain-induced protective immunity against pulmonary Francisella tularensis challenge is mediated by CD4+ T cells and antibodies, including immunoglobulin A. Clin Vaccine Immunol (2009) 1.12
A DNA vaccine targeting the receptor-binding domain of Clostridium difficile toxin A. Vaccine (2009) 1.08
Oral immunization with recombinant lactobacillus plantarum induces a protective immune response in mice with Lyme disease. Clin Vaccine Immunol (2008) 1.05
IL-13 production by regulatory T cells protects against experimental autoimmune encephalomyelitis independently of autoantigen. J Immunol (2008) 1.04
Α1-giardin based live heterologous vaccine protects against Giardia lamblia infection in a murine model. Vaccine (2011) 0.98
Flagella overexpression attenuates Salmonella pathogenesis. PLoS One (2012) 0.98
Expression of Escherichia coli virulence usher protein attenuates wild-type Salmonella. Virulence (2012) 0.96
Comparison of a regulated delayed antigen synthesis system with in vivo-inducible promoters for antigen delivery by live attenuated Salmonella vaccines. Infect Immun (2010) 0.94
A nasal interleukin-12 DNA vaccine coexpressing Yersinia pestis F1-V fusion protein confers protection against pneumonic plague. Infect Immun (2008) 0.92
Serum antibodies protect against intraperitoneal challenge with enterotoxigenic Escherichia coli. J Biomed Biotechnol (2011) 0.91
Progress in Brucella vaccine development. Front Biol (Beijing) (2013) 0.90
Principles of antidote pharmacology: an update on prophylaxis, post-exposure treatment recommendations and research initiatives for biological agents. Br J Pharmacol (2010) 0.89
Antibody selection for immobilizing living bacteria. Anal Chem (2009) 0.89
Attenuated Coxiella burnetii phase II causes a febrile response in gamma interferon knockout and Toll-like receptor 2 knockout mice and protects against reinfection. Infect Immun (2007) 0.88
Efficient immobilization and patterning of live bacterial cells. Langmuir (2008) 0.88
An encapsulated Yersinia pseudotuberculosis is a highly efficient vaccine against pneumonic plague. PLoS Negl Trop Dis (2012) 0.85
Efficacy and safety of a modified vaccinia Ankara (MVA) vectored plague vaccine in mice. Vaccine (2010) 0.85
Live-Attenuated Bacterial Vectors: Tools for Vaccine and Therapeutic Agent Delivery. Vaccines (Basel) (2015) 0.85
Vaccination of mice with salmonella expressing VapA: mucosal and systemic Th1 responses provide protection against Rhodococcus equi infection. PLoS One (2010) 0.85
The Asd(+)-DadB(+) dual-plasmid system offers a novel means to deliver multiple protective antigens by a recombinant attenuated Salmonella vaccine. Infect Immun (2012) 0.83
Protection against pneumonic plague following oral immunization with a non-replicating vaccine. Vaccine (2010) 0.83
A comparison of immunogenicity and protective immunity against experimental plague by intranasal and/or combined with oral immunization of mice with attenuated Salmonella serovar Typhimurium expressing secreted Yersinia pestis F1 and V antigen. FEMS Immunol Med Microbiol (2007) 0.81
Contribution of a Streptococcus mutans antigen expressed by a Salmonella vector vaccine in dendritic cell activation. Infect Immun (2011) 0.81
Developing live vaccines against plague. J Infect Dev Ctries (2011) 0.81
Vulnerabilities in Yersinia pestis caf operon are unveiled by a Salmonella vector. PLoS One (2012) 0.81
An IL-12 DNA vaccine co-expressing Yersinia pestis antigens protects against pneumonic plague. Vaccine (2008) 0.80
Evaluation of YadC protein delivered by live attenuated Salmonella as a vaccine against plague. Pathog Dis (2013) 0.80
Role of overexpressed CFA/I fimbriae in bacterial swimming. Phys Biol (2012) 0.79
A parenteral DNA vaccine protects against pneumonic plague. Vaccine (2010) 0.79
A bivalent typhoid live vector vaccine expressing both chromosome- and plasmid-encoded Yersinia pestis antigens fully protects against murine lethal pulmonary plague infection. Infect Immun (2014) 0.78
Attenuating gene expression (AGE) for vaccine development. Virulence (2013) 0.78
Oral administration of a recombinant attenuated Yersinia pseudotuberculosis strain elicits protective immunity against plague. Vaccine (2015) 0.76
A Recombinant Trivalent Fusion Protein F1-LcrV-HSP70(II) Augments Humoral and Cellular Immune Responses and Imparts Full Protection against Yersinia pestis. Front Microbiol (2016) 0.75
Plague Vaccine Development: Current Research and Future Trends. Front Immunol (2016) 0.75
A Tn7-based broad-range bacterial cloning and expression system. Nat Methods (2005) 4.66
Lipid raft microdomains: a gateway for compartmentalized trafficking of Ebola and Marburg viruses. J Exp Med (2002) 3.88
Kinetics of disease progression and host response in a rat model of bubonic plague. Am J Pathol (2005) 2.56
Transmission of Yersinia pestis from an infectious biofilm in the flea vector. J Infect Dis (2004) 2.52
Biomolecular characterization and protein sequences of the Campanian hadrosaur B. canadensis. Science (2009) 2.48
Innate and adaptive immune responses to an intracellular bacterium, Francisella tularensis live vaccine strain. Microbes Infect (2003) 2.48
Structural engineering of a phage lysin that targets gram-negative pathogens. Proc Natl Acad Sci U S A (2012) 2.36
Innate and adaptive immunity to Francisella. Ann N Y Acad Sci (2007) 2.32
Role of the Yersinia pestis plasminogen activator in the incidence of distinct septicemic and bubonic forms of flea-borne plague. Proc Natl Acad Sci U S A (2006) 2.31
Variation in lipid A structure in the pathogenic yersiniae. Mol Microbiol (2004) 2.28
Ebola virus-like particles protect from lethal Ebola virus infection. Proc Natl Acad Sci U S A (2003) 2.18
Depolymerization of beta-1,6-N-acetyl-D-glucosamine disrupts the integrity of diverse bacterial biofilms. J Bacteriol (2005) 2.16
Lung environment determines unique phenotype of alveolar macrophages. Am J Physiol Lung Cell Mol Physiol (2009) 2.10
Poor vector competence of fleas and the evolution of hypervirulence in Yersinia pestis. J Infect Dis (2005) 2.09
Intracellular biology and virulence determinants of Francisella tularensis revealed by transcriptional profiling inside macrophages. Cell Microbiol (2009) 2.00
Analyses of soft tissue from Tyrannosaurus rex suggest the presence of protein. Science (2007) 1.76
Adaptive response of Yersinia pestis to extracellular effectors of innate immunity during bubonic plague. Proc Natl Acad Sci U S A (2006) 1.66
Experimental evidence for negative selection in the evolution of a Yersinia pestis pseudogene. Proc Natl Acad Sci U S A (2008) 1.61
Resistance of Yersinia pestis to complement-dependent killing is mediated by the Ail outer membrane protein. Infect Immun (2007) 1.59
Direct and indirect impairment of human dendritic cell function by virulent Francisella tularensis Schu S4. Infect Immun (2008) 1.56
IL-35 stimulation of CD39+ regulatory T cells confers protection against collagen II-induced arthritis via the production of IL-10. J Immunol (2010) 1.53
Apple polyphenols require T cells to ameliorate dextran sulfate sodium-induced colitis and dampen proinflammatory cytokine expression. J Leukoc Biol (2011) 1.48
Role of natural killer cells in innate protection against lethal ebola virus infection. J Exp Med (2004) 1.44
Transit through the flea vector induces a pretransmission innate immunity resistance phenotype in Yersinia pestis. PLoS Pathog (2010) 1.36
Characterization of late acyltransferase genes of Yersinia pestis and their role in temperature-dependent lipid A variation. J Bacteriol (2006) 1.34
Regulatory T cell vaccination without autoantigen protects against experimental autoimmune encephalomyelitis. J Immunol (2007) 1.30
Identification of gmhA, a Yersinia pestis gene required for flea blockage, by using a Caenorhabditis elegans biofilm system. Infect Immun (2005) 1.30
Inducible bronchus-associated lymphoid tissue elicited by a protein cage nanoparticle enhances protection in mice against diverse respiratory viruses. PLoS One (2009) 1.23
Yersinia pestis YopJ suppresses tumor necrosis factor alpha induction and contributes to apoptosis of immune cells in the lymph node but is not required for virulence in a rat model of bubonic plague. Infect Immun (2006) 1.23
Deletion of znuA virulence factor attenuates Brucella abortus and confers protection against wild-type challenge. Infect Immun (2006) 1.21
Differential control of Yersinia pestis biofilm formation in vitro and in the flea vector by two c-di-GMP diguanylate cyclases. PLoS One (2011) 1.18
Selection of protective epitopes for Brucella melitensis by DNA vaccination. Infect Immun (2005) 1.18
Serotype differences and lack of biofilm formation characterize Yersinia pseudotuberculosis infection of the Xenopsylla cheopis flea vector of Yersinia pestis. J Bacteriol (2006) 1.16
Acute oral toxicity of Yersinia pseudotuberculosis to fleas: implications for the evolution of vector-borne transmission of plague. Cell Microbiol (2007) 1.16
Fimbriated Salmonella enterica serovar typhimurium abates initial inflammatory responses by macrophages. Infect Immun (2002) 1.14
The Yersinia pestis caf1M1A1 fimbrial capsule operon promotes transmission by flea bite in a mouse model of bubonic plague. Infect Immun (2008) 1.13
Virulence variation among isolates of western equine encephalitis virus in an outbred mouse model. J Gen Virol (2009) 1.11
Yersinia pestis subverts the dermal neutrophil response in a mouse model of bubonic plague. MBio (2013) 1.09
Plasminogen activator Pla of Yersinia pestis utilizes murine DEC-205 (CD205) as a receptor to promote dissemination. J Biol Chem (2008) 1.08
A live diarrheal vaccine imprints a Th2 cell bias and acts as an anti-inflammatory vaccine. J Immunol (2005) 1.06
Human dendritic cell-specific intercellular adhesion molecule-grabbing nonintegrin (CD209) is a receptor for Yersinia pestis that promotes phagocytosis by dendritic cells. Infect Immun (2008) 1.06
Interleukin-6 is essential for primary resistance to Francisella tularensis live vaccine strain infection. Infect Immun (2012) 1.05
Pulmonary hypertension can be a sequela of prior Pneumocystis pneumonia. Am J Pathol (2007) 1.05
IFN-β mediates suppression of IL-12p40 in human dendritic cells following infection with virulent Francisella tularensis. J Immunol (2011) 1.05
Transcriptomic and innate immune responses to Yersinia pestis in the lymph node during bubonic plague. Infect Immun (2010) 1.05
Generation of a convalescent model of virulent Francisella tularensis infection for assessment of host requirements for survival of tularemia. PLoS One (2012) 1.04
IL-13 production by regulatory T cells protects against experimental autoimmune encephalomyelitis independently of autoantigen. J Immunol (2008) 1.04
An insight into the sialome of the oriental rat flea, Xenopsylla cheopis (Rots). BMC Genomics (2007) 1.03
The presence of CD14 overcomes evasion of innate immune responses by virulent Francisella tularensis in human dendritic cells in vitro and pulmonary cells in vivo. Infect Immun (2009) 1.03
Loss of a biofilm-inhibiting glycosyl hydrolase during the emergence of Yersinia pestis. J Bacteriol (2008) 1.03
A novel role for plasmin-mediated degradation of opsonizing antibody in the evasion of host immunity by virulent, but not attenuated, Francisella tularensis. J Immunol (2009) 1.03
Kinetics of innate immune response to Yersinia pestis after intradermal infection in a mouse model. Infect Immun (2012) 1.01
Induction of the Yersinia pestis PhoP-PhoQ regulatory system in the flea and its role in producing a transmissible infection. J Bacteriol (2013) 1.01
Vaccination without autoantigen protects against collagen II-induced arthritis via immune deviation and regulatory T cells. J Immunol (2008) 1.01
Nanoparticles to increase adhesive properties of biologically secreted materials for surface affixing. J Biomed Nanotechnol (2009) 1.00
Ovalbumin-protein sigma 1 M-cell targeting facilitates oral tolerance with reduction of antigen-specific CD4+ T cells. Gastroenterology (2008) 1.00
Role of type I IFNs in pulmonary complications of Pneumocystis murina infection. J Immunol (2005) 0.99
Segregated regulatory CD39+CD4+ T cell function: TGF-β-producing Foxp3- and IL-10-producing Foxp3+ cells are interdependent for protection against collagen-induced arthritis. J Immunol (2011) 0.99
The Yersinia pestis Rcs phosphorelay inhibits biofilm formation by repressing transcription of the diguanylate cyclase gene hmsT. J Bacteriol (2012) 0.98
Flagella overexpression attenuates Salmonella pathogenesis. PLoS One (2012) 0.98
HEPES-stabilized encapsulation of Salmonella typhimurium. Langmuir (2007) 0.97
Structural insights into Ail-mediated adhesion in Yersinia pestis. Structure (2011) 0.97
Effective, broad spectrum control of virulent bacterial infections using cationic DNA liposome complexes combined with bacterial antigens. PLoS Pathog (2010) 0.97
Lipids derived from virulent Francisella tularensis broadly inhibit pulmonary inflammation via toll-like receptor 2 and peroxisome proliferator-activated receptor α. Clin Vaccine Immunol (2013) 0.97
Low-dose tolerance is mediated by the microfold cell ligand, reovirus protein sigma1. J Immunol (2008) 0.97
M cell DNA vaccination for CTL immunity to HIV. J Immunol (2003) 0.96
Infection of mice with Francisella as an immunological model. Curr Protoc Immunol (2011) 0.96
Development of functional and molecular correlates of vaccine-induced protection for a model intracellular pathogen, F. tularensis LVS. PLoS Pathog (2012) 0.96
Flea-borne transmission model to evaluate vaccine efficacy against naturally acquired bubonic plague. Infect Immun (2004) 0.96
Yersinia--flea interactions and the evolution of the arthropod-borne transmission route of plague. Curr Opin Microbiol (2012) 0.96
Expression of Escherichia coli virulence usher protein attenuates wild-type Salmonella. Virulence (2012) 0.96
Yersinia pestis survival and replication within human neutrophil phagosomes and uptake of infected neutrophils by macrophages. J Leukoc Biol (2013) 0.95
A novel neurotoxoid vaccine prevents mucosal botulism. J Immunol (2005) 0.95
Molecular mechanisms of filovirus cellular trafficking. Microbes Infect (2003) 0.95
Long lived protection against pneumonic tularemia is correlated with cellular immunity in peripheral, not pulmonary, organs. Vaccine (2010) 0.94
Protective live oral brucellosis vaccines stimulate Th1 and th17 cell responses. Infect Immun (2011) 0.94
Enhanced immunoglobulin A response and protection against Salmonella enterica serovar typhimurium in the absence of the substance P receptor. Infect Immun (2005) 0.93
Low dose vaccination with attenuated Francisella tularensis strain SchuS4 mutants protects against tularemia independent of the route of vaccination. PLoS One (2012) 0.93
Nasal Acai polysaccharides potentiate innate immunity to protect against pulmonary Francisella tularensis and Burkholderia pseudomallei Infections. PLoS Pathog (2012) 0.93
Expression and immunogenicity of an Escherichia coli K99 fimbriae subunit antigen in soybean. Planta (2004) 0.92
A nasal interleukin-12 DNA vaccine coexpressing Yersinia pestis F1-V fusion protein confers protection against pneumonic plague. Infect Immun (2008) 0.92